Kanya Rajangam

Heparin Binding Nanostructures to Promote Growth of Blood Vessels

Kanya Rajangam, Heather A. Behanna, Michael J. Hui et al. · Nano Letters · 2006 · 411 citations

Nanoparticles, Tissue Engineering, Engineering +18

Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies

David Siegel, Thomas G Martin, A. Nooka et al. · Haematologica · 2013 · 338 citations · Full text

Pharmacotherapy, Hematological Malignancy, Thrombosis +16

Peptide amphiphile nanostructure–heparin interactions and their relationship to bioactivity

Kanya Rajangam, Michael S. Arnold, Mark A. Rocco et al. · Biomaterials · 2008 · 123 citations · Full text

Peptide Engineering, Peptide Science, Amphiphilic System +1

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Roman Hájek, Tamás Masszi, Maria Teresa Petrucci et al. · Leukemia · 2016 · 118 citations · Full text

Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases

Matthew J. Webber, Xiaoqiang Han, S. N. Prasanna Murthy et al. · Journal of Tissue Engineering and Regenerative Medicine · 2010 · 95 citations

Nanoparticles, Tissue Engineering, Engineering +25